CONTEXT: Because androgens are obligatory precursors of estrogens, it is reasonable to assume that their serum concentrations would exhibit positive correlations. If so, then epidemiologic studies that examine the association between androgens and pathological processes should adjust the results for the independent effect of estrogens. OBJECTIVE: The objective of the study was to examine the interrelationships among testosterone (T), androstenedione, estradiol (E2), estrone, and SHBG in postmenopausal women. DESIGN: This was a cross-sectional study of women participating in the National Heart, Blood, and Lung Institute-sponsored Women's Ischemia Syndrome Evaluation study. SETTING: The study was conducted at four academic medical centers. PATIENTS: A total of 284 postmenopausal women with chest pain symptoms or suspected myocardial ischemia. MAIN OUTCOME MEASURES: Post hoc analysis of the relationships among sex steroid hormones with insulin resistance, body mass index (BMI), and presence or absence of coronary artery disease as determined by coronary angiography. RESULTS: BMI was significantly associated with insulin resistance, total E2, free E2, bioavailable E2, and free T. Highly significant correlations were found for total T, free T, and androstenedione with total E2, free E2, bioavailable E2, and estrone and persisted after adjustment for BMI and insulin resistance. A significant relationship was present between total and free T and the presence of coronary artery disease after adjustment for the effect of E2. CONCLUSIONS: Serum levels of androgens and estrogens track closely in postmenopausal women referred for coronary angiography for suspected myocardial ischemia. Epidemiological studies that relate sex steroid hormones to physiological or pathological processes need to control for the independent effect of both estrogens and androgens.
CONTEXT: Because androgens are obligatory precursors of estrogens, it is reasonable to assume that their serum concentrations would exhibit positive correlations. If so, then epidemiologic studies that examine the association between androgens and pathological processes should adjust the results for the independent effect of estrogens. OBJECTIVE: The objective of the study was to examine the interrelationships among testosterone (T), androstenedione, estradiol (E2), estrone, and SHBG in postmenopausal women. DESIGN: This was a cross-sectional study of women participating in the National Heart, Blood, and Lung Institute-sponsored Women's Ischemia Syndrome Evaluation study. SETTING: The study was conducted at four academic medical centers. PATIENTS: A total of 284 postmenopausal women with chest pain symptoms or suspected myocardial ischemia. MAIN OUTCOME MEASURES: Post hoc analysis of the relationships among sex steroid hormones with insulin resistance, body mass index (BMI), and presence or absence of coronary artery disease as determined by coronary angiography. RESULTS: BMI was significantly associated with insulin resistance, total E2, free E2, bioavailable E2, and free T. Highly significant correlations were found for total T, free T, and androstenedione with total E2, free E2, bioavailable E2, and estrone and persisted after adjustment for BMI and insulin resistance. A significant relationship was present between total and free T and the presence of coronary artery disease after adjustment for the effect of E2. CONCLUSIONS: Serum levels of androgens and estrogens track closely in postmenopausal women referred for coronary angiography for suspected myocardial ischemia. Epidemiological studies that relate sex steroid hormones to physiological or pathological processes need to control for the independent effect of both estrogens and androgens.
Authors: Agnieszka Kaczmarek; Krzysztof Reczuch; Jacek Majda; Waldemar Banasiak; Piotr Ponikowski Journal: Int J Cardiol Date: 2003-01 Impact factor: 4.164
Authors: S E Hankinson; W C Willett; J E Manson; G A Colditz; D J Hunter; D Spiegelman; R L Barbieri; F E Speizer Journal: J Natl Cancer Inst Date: 1998-09-02 Impact factor: 13.506
Authors: Herbert Yu; Xiao-Ou Shu; Runhua Shi; Qi Dai; Fan Jin; Yu-Tang Gao; Benjamin D L Li; Wei Zheng Journal: Int J Cancer Date: 2003-05-20 Impact factor: 7.396
Authors: Kathryn M Rexrode; JoAnn E Manson; I-Min Lee; Paul M Ridker; Patrick M Sluss; Nancy R Cook; Julie E Buring Journal: Circulation Date: 2003-09-15 Impact factor: 29.690
Authors: Susan R Sturgeon; Nancy Potischman; Kathleen E Malone; Joanne F Dorgan; Janet Daling; Cathy Schairer; Louise A Brinton Journal: Cancer Causes Control Date: 2004-02 Impact factor: 2.506
Authors: Jonas Manjer; Robert Johansson; Göran Berglund; Lars Janzon; Rudolf Kaaks; Asa Agren; Per Lenner Journal: Cancer Causes Control Date: 2003-09 Impact factor: 2.506
Authors: Annekatrin Lukanova; Eva Lundin; Andrea Micheli; Alan Arslan; Pietro Ferrari; Sabina Rinaldi; Vittorio Krogh; Per Lenner; Roy E Shore; Carine Biessy; Paola Muti; Elio Riboli; Karen L Koenig; Mortimer Levitz; Pär Stattin; Franco Berrino; Göran Hallmans; Rudolf Kaaks; Paolo Toniolo; Anne Zeleniuch-Jacquotte Journal: Int J Cancer Date: 2004-01-20 Impact factor: 7.396
Authors: A Zeleniuch-Jacquotte; R E Shore; K L Koenig; A Akhmedkhanov; Y Afanasyeva; I Kato; M Y Kim; S Rinaldi; R Kaaks; P Toniolo Journal: Br J Cancer Date: 2004-01-12 Impact factor: 7.640
Authors: Chevon M Rariy; Sarah J Ratcliffe; Rachel Weinstein; Shalender Bhasin; Marc R Blackman; Jane A Cauley; John Robbins; Joseph M Zmuda; Tamara B Harris; Anne R Cappola Journal: J Clin Endocrinol Metab Date: 2011-02-02 Impact factor: 5.958
Authors: L B Harrington; B T Marck; K L Wiggins; B McKnight; S R Heckbert; N F Woods; A Z LaCroix; M Blondon; B M Psaty; F R Rosendaal; A M Matsumoto; N L Smith Journal: J Thromb Haemost Date: 2017-01-08 Impact factor: 5.824
Authors: Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; Anna Maria Corsi; Francesco Giallauria; Jack M Guralnik; Giovanni Zuliani; Chiara Cattabiani; Stefano Parrino; Fabrizio Ablondi; Elisabetta Dall'aglio; Graziano Ceresini; Shehzad Basaria; Luigi Ferrucci Journal: J Clin Endocrinol Metab Date: 2011-01-14 Impact factor: 5.958
Authors: Chrisandra Shufelt; C Noel Bairey Merz; YuChing Yang; Joan Kirschner; Donna Polk; Frank Stanczyk; Maura Paul-Labrador; Glenn D Braunstein Journal: J Womens Health (Larchmt) Date: 2011-12-07 Impact factor: 2.681
Authors: Shrita M Patel; Nayyar Iqbal; Shailja Kaul; Sarah J Ratcliffe; Michael R Rickels; Muredach P Reilly; Theresa Scattergood; Arpita Basu; Carissa Fuller; Anne R Cappola Journal: Fertil Steril Date: 2010-03-12 Impact factor: 7.329
Authors: Patrick D Olson; Lisa K McLellan; Teri N Hreha; Alice Liu; Kelleigh E Briden; Keith A Hruska; David A Hunstad Journal: Kidney Int Date: 2018-07-03 Impact factor: 10.612